Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Apr 13, 2007 at 4:35 AM EDT

Someone At Merck Is Crazy

Merck’s new arthritis drug Arcoxia was rejected by an FDA panel by a vote of 20-to-1. Apparently, the drug has…

Douglas A. McIntyre | Apr 13, 2007 at 2:46 AM EDT

Thursday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 12, 2007 at 3:00 PM EDT

Cramer Looking For the Next Dendreon

Cramer said in a video this afternoon on TheStreet.com that this Dendreon (DNDN-NASDAQ) is a classic case of short sellers…

Douglas A. McIntyre | Apr 12, 2007 at 8:01 AM EDT

MedImmune Decides To Pursue a Sale

MedImmune, Inc. (MEDI-NASDAQ) announced that its board of directors has authorized management to evaluate whether third parties would have an…

Douglas A. McIntyre | Apr 12, 2007 at 3:15 AM EDT

Wednesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 12, 2007 at 3:13 AM EDT

BioWatch Alert: eXegenics Jumps 10% on Strong Volume, No News!

by H.S. AyoubBioHealthInvestor.com

Douglas A. McIntyre | Apr 11, 2007 at 3:13 PM EDT

Genentech Cruised Past Estimates

Genetech (DNA-NYSE) posted earnings: $0.74 EPS and revenues were $2.843 Billion; expectations were $0.67 EPS & R$2.74 Billion. The stock…

Douglas A. McIntyre | Apr 11, 2007 at 7:53 AM EDT

Cell Genesys Slips New Holders a Mickey

Cell Genesys, Inc. (CEGE-NASDAQ) has done what many small biotechs do that are in need of cash: sell shares in…

Douglas A. McIntyre | Apr 11, 2007 at 6:50 AM EDT

Dendreon Downgraded, Sort Of…..

Dendreon (DNDN-NASDAQ) is trading down more than 4% at $21.25 in early trading after JMP Securities downgraded the shares. DNDN…

Douglas A. McIntyre | Apr 11, 2007 at 2:59 AM EDT

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 10, 2007 at 4:02 PM EDT

Amgen CFO Walks Out; Any More Execs Leaving?

Amgen (AMGN-NASDAQ) is naming a new CFO. Robert Bradway is replacing Richard Nanula, who is leaving to pursue other opportunities. …

Douglas A. McIntyre | Apr 10, 2007 at 1:41 PM EDT

Adolor: Is There Anything Left?

Adolor Corp. (ADLR-NASDAQ) may have just joined the ranks of current and future biotech zombies. The company suspended its lead…

Douglas A. McIntyre | Apr 10, 2007 at 3:20 AM EDT

Monday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 9, 2007 at 3:36 AM EDT

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor

Douglas A. McIntyre | Apr 9, 2007 at 3:34 AM EDT

BioWatch Alert: Repligen Jumps on Higher Volume, No News!

by H.S. AyoubBioHealthInvestor.com

1 … 373 374 375 376 377 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Someone At Merck Is Crazy

Thursday’s Top Biotech & Medical Stocks

Cramer Looking For the Next Dendreon

MedImmune Decides To Pursue a Sale

Wednesday’s Top Biotech & Medical Stocks

BioWatch Alert: eXegenics Jumps 10% on Strong Volume, No News!

Genentech Cruised Past Estimates

Cell Genesys Slips New Holders a Mickey

Dendreon Downgraded, Sort Of…..

Tuesday’s Top Biotech & Medical Stocks

Amgen CFO Walks Out; Any More Execs Leaving?

Adolor: Is There Anything Left?

Monday’s Top Biotech & Medical Stocks

IBD Weekly Top Ranked Medical Stocks

BioWatch Alert: Repligen Jumps on Higher Volume, No News!

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Health and Healthcare Articles

All Health and Healthcare Articles

Someone At Merck Is Crazy

Thursday’s Top Biotech & Medical Stocks

Cramer Looking For the Next Dendreon

MedImmune Decides To Pursue a Sale

Wednesday’s Top Biotech & Medical Stocks

BioWatch Alert: eXegenics Jumps 10% on Strong Volume, No News!

Genentech Cruised Past Estimates

Cell Genesys Slips New Holders a Mickey

Dendreon Downgraded, Sort Of…..

Tuesday’s Top Biotech & Medical Stocks

Amgen CFO Walks Out; Any More Execs Leaving?

Adolor: Is There Anything Left?

Monday’s Top Biotech & Medical Stocks

IBD Weekly Top Ranked Medical Stocks

BioWatch Alert: Repligen Jumps on Higher Volume, No News!

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Featured Reads

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62